why choose us

First received: June 05, 2023

Clinical Trial: 68Ga-NY104 PET/CT Imaging in Renal Cell Carcinoma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Renal Cell Carcinoma

Study Type: INTERVENTIONAL


Official Title: 68Ga-NY104 PET/CT Imaging in Patients With Confirmed or Suspicious Renal Cell Carcinoma

Brief Summary: This is a prospective, single-center study in patients with renal cell carcinoma.The goal is to determine the sensitivity and specificity of 68Ga-NY104 PET/CT in the detection of clear cell renal cell carcinoma.

Read more